Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
|Articles|May 5, 2023
Supplements and Featured Publications
- A Review of the Current Management and Burden of Prurigo Nodularis in the United States
Participating Faculty: A Review of the Current Management and Burden of Prurigo Nodularis in the United States
Author(s)Sarah S. Chisolm, MD
Advertisement
Faculty
Sarah S. Chisolm, MD
Assistant Professor
Department of Dermatology
Emory University
Atlanta, Georgia
Managing Director
ITCH-E (Itch Translational and Clinical Home at Emory)
Emory University
Atlanta, Georgia
Staff Physician
Department of Veterans Affairs Medical Center
VISN 7
Decatur, Georgia
Faculty Disclosures
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Sarah S. Chisolm, MD
Paid Advisory Boards
Sanofi; Regeneron Pharmaceuticals, Inc; Galderma
Articles in this issue
Advertisement
Related to this article
Home NB-UVB phototherapy matches office results, boosts psoriasis treatment adherence, and may improve access, but long-term safety, equity, and oversight lag.
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
Baricitinib is now FDA approved for adolescents 12 and older with severe alopecia areata, extending the once-daily pill beyond adults.
A new type of eye drug matched standard anti-VEGF therapy in a large trial for diabetic macular edema, a disease affecting 1.6 million Americans.
At a Stakeholder Interchange convened by The American Journal of Managed Care® in Tampa, Florida, an academic-community mix of hematologist-oncologists and pharmacists debated prior authorization, site-of-care payment disparities, and how aggressively to push bispecific antibody regimens to community practices treating patients with relapsed/refractory multiple myeloma.
Portuguese patch testing finds many chronic hand eczema cases link to allergic contact dermatitis—especially occupational exposures like methylisothiazolinone, HEMA acrylates, thiuram mix, nickel.
Advertisement
Advertisement
Trending on AJMC
1
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
2
Tavapadon for Parkinson Disease Approved by FDA
3
Health System Pharmacies Keep Patients on GLP-1 Therapy
4
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
5